secretagogue raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-08-08 and is reviewed periodically as new material appears.
Compared with other secretagogues such as GHRP-2, GHRP-6, and hexarelin, ipamorelin is described as more selective. Published animal work reports little or no increase in adrenocorticotropic hormone, cortisol, or prolactin at doses that release growth hormone. This selectivity is the property most often cited in the research literature. Whether the same profile holds across species and dosing schedules remains an open question, since human data are limited and come largely from small studies.
Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue family. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, and its molecular mass is approximately 711.9 daltons. The compound was described in the late 1990s by researchers seeking molecules that release growth hormone with fewer side effects than earlier secretagogues. It is a laboratory and research compound, not an approved medicine in most jurisdictions.
现有文献多来自小规模、短期的研究，涉及生长激素缺乏、术后肠麻痹等方向。长期使用是否导致受体脱敏，以及重复给药后效应是否衰减，仍属开放问题。不同研究之间的剂量、给药途径和受试者特征差异较大，因此结论外推需谨慎。关于临床获益的确切证据尚不充分，需要更大规模的对照试验来澄清。
Ipamorelin 是一种合成五肽，在 20 世纪 90 年代被报道为生长激素促分泌剂。其结构基于胃饥饿素受体激动剂的设计思路，但并非天然激素。早期药理学研究显示，它可刺激垂体释放生长激素，而对应激激素轴的影响相对较小。该化合物常被用作研究生长激素调节通路的工具分子。
在机制层面，ipamorelin 与生长激素促分泌受体 1a 型结合，该受体也介导胃饥饿素的多种效应。受体激活后，细胞内信号促进生长激素从垂体前叶释放。由于对促肾上腺皮质激素和皮质醇的刺激较弱，它被视为选择性较高的促分泌剂。这种选择性在动物模型和少量人体研究中被观察到，但人体数据仍然有限。
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic pentapeptide | Growth hormone secretagogue family |
| Molecular mass | Approximately 711.9 Da | Free base, calculated value |
| Receptor target | GHS-R1a, the ghrelin receptor | Agonist activity reported |
| Sequence | Aib-His-D-2-Nal-D-Phe-Lys-NH2 | C-terminal amide |
| Reported selectivity | Little change in ACTH, cortisol, prolactin | Based mainly on animal data |
Published discussion of this compound is uneven. Some references describe it as a tool for probing growth hormone regulation, while others focus on analytical characterization or on comparisons with related secretagogues. Statements about selectivity, half-life and potency often trace back to a small number of original reports that later authors cite secondhand. Readers evaluating a claim should therefore check whether a figure reflects a direct measurement or a repeated citation, and whether the underlying study was conducted in animals, in isolated cells or in human volunteers.
Identity and purity assessment for a research peptide of this kind typically combines reversed-phase high-performance liquid chromatography with mass spectrometry. The chromatographic run separates related impurities and yields a purity percentage, while electrospray ionization or matrix-assisted laser desorption mass spectrometry confirms the expected molecular mass. Amino acid analysis or tandem mass spectrometry sequencing can add confidence when material is intended for quantitative work. Laboratories differ in how they calculate and report purity, so figures from different sources are not always directly comparable.
Lyophilized material is generally stored cold and dry, with desiccant, and protected from light. In solution the peptide is more vulnerable: the histidine side chain can oxidize, and repeated freeze-thaw cycles promote aggregation and loss of material to container surfaces. A mildly acidic aqueous buffer is often used for short-term handling because it limits several degradation routes. Accurate prediction of long-term stability under a given set of conditions is difficult, and published stability data remain sparse.
Structural features distinguish the molecule from earlier secretagogues. An alpha-aminoisobutyric acid residue near the N-terminus and a D-naphthylalanine substitution increase receptor affinity, while C-terminal amidation improves resistance to exopeptidases. These modifications are associated with reduced stimulation of appetite and of the hypothalamic-pituitary-adrenal axis compared with hexarelin or growth hormone releasing peptide-6. Whether the same profile applies at every dose level studied is a matter of ongoing investigation rather than settled consensus.
Ipamorelin is a synthetic pentapeptide that acts as an agonist at the ghrelin receptor, also called the growth hormone secretagogue receptor type 1a. Its sequence incorporates non-natural residues, which slows enzymatic breakdown relative to short native peptides. In laboratory and early clinical work the compound is described as a selective growth hormone secretagogue because it raises growth hormone with comparatively little effect on other pituitary outputs. The degree to which that selectivity holds across species and dosing regimens remains an open question in the published literature.
Signal transduction begins when the peptide binds GHSR-1a on pituitary somatotrophs. The receptor couples to Gq/11 proteins, activating phospholipase C, which cleaves phosphatidylinositol bisphosphate into inositol trisphosphate and diacylglycerol. Inositol trisphosphate releases calcium from intracellular stores, and the resulting rise in cytosolic calcium drives growth hormone vesicle fusion. Concurrent Gs coupling and cyclic AMP elevation have also been reported, and the relative contribution of each arm to the overall secretory response is not fully settled.
Storage recommendations for ipamorelin usually focus on temperature, moisture, and light. Lyophilized powder is typically held at or below minus twenty degrees Celsius in a desiccated container protected from light. Reconstituted solutions are often aliquoted and stored at minus eighty degrees Celsius to reduce repeated freeze-thaw cycles, which can promote aggregation or degradation. The optimal buffer and pH depend on the specific assay, and no single condition applies to every experimental context. Peptide stability should be assessed with time-point measurements rather than assumed from general handling rules.
In the scientific literature, ipamorelin appears mainly in preclinical studies, receptor binding assays, and reviews of growth hormone secretagogues. Authors often discuss its selectivity profile alongside limitations such as small sample sizes, short study durations, and differences between species. Some papers examine pharmacokinetics and clearance, but human data are limited and not sufficient to define general clinical effects. Regulatory discussion treats the compound as an investigational or research substance rather than an approved therapy in most jurisdictions. Open questions include oral bioavailability, long-term endocrine effects, and whether selectivity observed in animals persists in humans.
Research peptides such as ipamorelin are commonly supplied as lyophilized powder and characterized by analytical certificates. Reversed-phase high-performance liquid chromatography is used to estimate purity by ultraviolet absorbance, while mass spectrometry confirms molecular identity and detects sequence-related impurities. Counterion content, water content, and residual synthesis reagents can affect the reported mass balance. A certificate of analysis may list a purity percentage, but that number depends on the analytical method and the definition of impurity peaks. Independent verification is often recommended because research supply chains vary in quality control practices.
== Early life and education == Abdel Fattah al-Burhan was born in 1960 in the village of Gandatu in northern Sudan, to a Ja'ali family. Al-Burhan studied elementary and intermediate level in his village school, and later moved to Shendi to complete his education before joining the Sudanese Military College.
== Description == The fruiting body is varying in size, and can be 5–30 centimetres (2–12 in) tall and 4–20 cm (1+1⁄2–8 in). Immatures have been described to be oblong, somewhat resembling the shape of a rugby ball. There is some variation in coloration, and mature Pisolithus Arhizus feature a shiny gray/brown shell with darker and lighter/whitish/yellowish patches depending on the specimen. As it ages, the fungus can develop a rudimentary stipe or stem, although not all will do this. It also tends to open up, exposing "cracks and fissures, and eventually breaking up to expose the interior." This outer peridium is roughly 1mm thick and within it can be found a mass of pea-sized "pseudoperidioles" which are structures that contain and produce spores, and are fixed in a dark gel. As a reproductive strategy, P.arhizus will release spores to the wind as the peridium turns dry and crumbly/powdery with time. The fungus has non-ornamental spores that are described as "khaki" or "cinnamon" brown, and measure roughly 5-8µm in size.
Different 2A peptides have different peptide-bond-skipping efficiencies, with T2A and P2A being the most efficient and F2A the least efficient. Therefore, up to 50% of F2A-linked proteins can in fact be produced as a fusion protein, which might cause some unpredictable outcomes, including a gain of function. One study reported that 2A sites cause the ribosome to fall off approximately 60% of the time, and that, together with ribosome read-through of about 10% for P2A and T2A, this results in reducing expression of the downstream peptide chain by about 70%. However, the level of drop-off detected in this study varied widely depending on the exact construct used, with some constructs showing little evidence of drop-off; furthermore, within a tri-cistronic transcript it reported a higher level of ribosome drop-off after one 2A sequence than after two 2As combined, which is at odds with a linear model of translation. IRES Recombinant DNA
=== Post-launch updates === Following the game’s release, Turtle Rock Studios took the lead in the ongoing development of Counter-Strike: Source, adding new content and features through post-launch updates. From December 2004 to January 2006, the studio remade six classic maps from previous Counter-Strike titles that were missing at launch, introduced bot support, and fixed various bugs and exploits. During the same period, Valve also expanded the game’s content and visual quality by releasing three maps, including one remake from the original Counter-Strike and two entirely new maps, while also upgrading the default player models. Between December 2005 and April 2006, the remaining classic player models were restored, and in August 2006 the radar was redesigned into a mini-map-style display that introduced enemy detection as part of its updated functionality. In December 2005, Valve introduced HDR lighting technology, which was gradually implemented across several maps throughout 2006. In November 2006, the Dynamic Weapon Pricing system was introduced, which altered weapon prices weekly based on player demand statistics from the previous week. The system was intended to encourage the use of a wider range of weapons, but faced immediate criticism from the community because prices could fluctuate dramatically, with popular weapons becoming prohibitively expensive while less desirable weapons could become extremely cheap. Despite attempts to improve and rebalance the system, it was eventually abandoned and later removed.
The theory further states that removing opiate precursors from a child's diet may allow time for these behaviors to cease, and neurological development in very young children to resume normally. As of 2021, reliable studies have not demonstrated the benefit of gluten-free diets in the treatment of autism. In the subset of people who have gluten sensitivity there is limited evidence that suggests that a gluten-free diet may improve some autistic behaviors.
Sources: en.wikipedia.org
In February 2011, the European Commission's Committee for Medicinal Products for Human Use approved the product for the treatment of Dupuytren's contracture in adults with a palpable cord by 'properly trained' doctors. Pfizer was reported to be working with Europe's national medicines regulatory bodies to launch the new treatment, hoping doctors could prescribe the treatment by late 2011. On November 7, 2012, BioSpecifics announced "BioSpecifics Technologies Corp. : Reports Third Quarter 2012 Financial Results". Auxilium's submission of a License Application to the FDA for Xiaflex for the potential treatment of Peyronie's disease, an excess of inelastic collagen causing penile curvature deformity. The FDA approved Xiaflex for the treatment of Peyronie’s disease in December 2013. Following this, Xiapex gained EU approval for the treatment of Peyronie’s disease in February 2015, making it the first and only biologic therapy indicated for the treatment of Peyronie's disease. Auxilium has also reported additional trials for potential use of Xiaflex are underway for the treatment of frozen shoulder, cellulite reductions and both human and canine lipomas. In March 2020, the Swedish manufacturer abruptly withdrew distribution of this drug in Europe for commercial reasons. Collagenase is no longer available on the National Health System except as part of a small clinical trial.
It was definitively accepted by the Fédération Cynologique Internationale in 1954. In the fifteen years from 2007 to 2021, the annual number of new registrations in Germany averaged about 485, with a low of 390 and a high of 607.
== Further reading == Biot, René. (1962). The Enigma of the Stigmata. Hawthorn Books. Carroll, Robert Todd. (2003). Stigmata. In The Skeptic's Dictionary. Wiley. ISBN 978-0-471-27242-7 Harrison, Ted. (1994). Stigmata: A Medieval Phenomenon in a Modern Age. St Martins Press. ISBN 0-312-11372-2 Mazzoni, Cristina. (1996). Saint Hysteria: Neurosis, Mysticism, and Gender in European Culture. Cornell University Press. ISBN 0-8014-3229-4 Nickell, Joe. (1993). Looking for a Miracle: Weeping Icons, Relics, Stigmata, Visions & Healing Cures. Prometheus Books. ISBN 1-57392-680-9 Radford, Benjamin. (2014). What is Stigmata?. LiveScience. Retrieved 12 May 2016. Wilson, Ian. (1988). The Bleeding Mind: An Investigation into the Mysterious Phenomena of Stigmata. Weidenfeld & Nicolson. ISBN 0-297-79099-4 Yarom, Nitza. (1992). Body, Blood, and Sexuality: A Psychoanalytic Study of St. Francis' Stigmata and Their Historical Context. Peter Lang Publisher. Van Osselaer, Tina; Graus, Andrea; Rossi, Leonardo; Smeyers, Kristof (12 October 2020). The Devotion and Promotion of Stigmatics in Europe c. 1800–1950, between Saints and Celebrities (PDF). Numen Book Series-Studies in the History of Religions. Vol. 167. Leiden, Boston: Brill. p. 487. ISBN 978-90-04-43935-1. ISSN 0169-8834. LCCN 2020031449. Archived (PDF) from the original on September 9, 2021.
Since radioactive decay is exponential with a constant probability, each process could as easily be described with a different constant time period that (for example) gave its "(1/3)-life" (how long until only 1/3 is left) or "(1/10)-life" (a time period until only 10% is left), and so on. Thus, the choice of τ and t1/2 for marker-times, are only for convenience, and from convention. They reflect a fundamental principle only in so much as they show that the same proportion of a given radioactive substance will decay, during any time-period that one chooses. Mathematically, the nth life for the above situation would be found in the same way as above—by setting N = N0/n, t = T1/n and substituting into the decay solution to obtain
=== Computing and telecommunications === Adaptive delta modulation, a digital-to-analog data conversion technique Add-drop multiplexer, in optical fiber networks Administrative Template, in Microsoft Windows Group Policy deployment ADM-3A, a computer terminal manufactured by Lear Siegler Application development and maintenance in Lean IT Architecture Development Method, a component of The Open Group Architecture Framework Architecture-driven modernization of legacy software Automated decision-making
Sources: en.wikipedia.org
== Organizational structure == The Commission consists of the chairman and other members appointed by the President of the Republic of India. Usually, the Commission consists of 9 to 11 members, including the chairman. Every member holds office for a term of six years or until he attains the age of sixty-five years, whichever is earlier. The terms and conditions of service of the chairman and members of the commission are governed by the Union Public Service Commission (Members) Regulations, 1969. The chairman and any other member of the commission can submit their resignation at any time to the President of India. They may be removed from their office by the President of India on the ground of misbehavior (only if an inquiry of such misbehavior is made and upheld by the Supreme Court) or if he is adjudged insolvent, or engages during the term of office in any paid employment outside the duties of their office, or in the opinion of the president unfit to continue in office because of the infirmity of mind or body.
== Synthesis == It can be synthesized from catechol first by conversion to methylenedioxybenzene, which is brominated and coupled with allyl bromide. Safrole is a versatile precursor to many compounds. Examples are N-acylarylhydrazones and isosters, aryl-sulfonamide derivatives, acidic sulfonylhydrazone derivatives, benzothiazine derivatives and many more.
On October 2, 2025, FIFA announced the video game FIFA Heroes, scheduled for release in 2026 on Android, iOS, Nintendo Switch, PlayStation, and Xbox platforms. In May 2026, the Football Manager 26 video game also announced the addition of licensed 2026 FIFA World Cup content. In December 2025, Netflix announced a new simulation-type game featuring the World Cup, produced by Delphi Interactive and Refactor Games. In May 2026, it was announced the Netflix-published game would be titled FIFA World Cup: Launch Edition; it was released in June 2026. In the same May 2026 announcement, FIFA also confirmed that they would adopt a non-exclusive "Digital Football" ecosystem, with games of various genres adopting the FIFA license. Alongside the new World Cup game were FIFA Heroes, FIFA Rivals, FIFA Super Soccer, Football Manager, eFootball and Rocket League, with more games joining the ecosystem in the following months.
Pralmorelin (INN; brand name GHRP Kaken 100; former developmental codes KP-102, GPA-748, and WAY-GPA-748; also known as pralmorelin hydrochloride (JAN), pralmorelin dihydrochloride (USAN), growth hormone-releasing peptide 2, and GHRP-2) is a growth hormone secretagogue (GHS) used as a diagnostic agent that is marketed by Kaken Pharmaceutical in Japan in a single-dose formulation for the assessment of growth hormone deficiency (GHD). Pralmorelin is an orally-active, synthetic peptide drug, specifically, an analogue of met-enkephalin, with the amino acid sequence D-Ala-D-(β-naphthyl)-Ala-Trp-D-Phe-Lys-NH2. It acts as a ghrelin/growth hormone secretagogue receptor (GHSR) agonist, and was the first of this class of drugs to be introduced clinically. Acute administration of the drug markedly increases the levels of plasma growth hormone (GH) and reliably induces sensations of hunger and increases food intake in humans. Pralmorelin was also under investigation for the treatment of GHD and short stature (pituitary dwarfism), and made it to phase II clinical trials for these indications, but was ultimately never marketed for them. This may be because the ability of pralmorelin to increase plasma GH levels is significantly lower in people with GHD relative to healthy individuals.
== See also == List of organs of the human body Hydrostatic weighing Dietary element Composition of blood List of human blood components Body composition Abundance of elements in Earth's crust Abundance of the chemical elements
Sources: en.wikipedia.org
Ipamorelin is a synthetic pentapeptide that stimulates growth hormone release by activating the ghrelin receptor. It is handled as a research tool rather than as a licensed therapeutic product. Its short chain length makes it comparatively simple to synthesize and analyze.
Both bind the same receptor, but ghrelin is a 28-amino-acid hormone with roles in appetite and energy balance. Ipamorelin is a much smaller synthetic peptide selected for growth hormone release with limited effect on appetite signaling in animal models. The full overlap between their effects is not completely mapped.
Most published data come from animal studies and a small number of human trials. Findings on growth hormone release are reasonably consistent, while long-term effects and direct comparisons with other secretagogues remain incompletely studied. Open questions include duration of action across different populations.
不是。它属于人工合成的五肽，设计上模拟胃饥饿素受体的部分作用，但不存在于人体天然激素谱中。